Abstract. Altered D-glucose metabolism prevails in the soleus muscle of rats depleted in long-chain polyunsaturated ω3 fatty acids (ω3). In these animals, the prior intravenous injection of an ω3-rich medium-chain triglyceride:fish oil emulsion (ω3-FO rats), as compared to that of an ω3-poor medium-chain triglyceride:olive oil emulsion (ω3-OO rats), may either correct or aggravate selected metabolic variables. This study deals with the fatty acid pattern of soleus phospholipids and triglycerides in control animals versus ω3-depleted rats not injected with any lipid emulsion (ω3-NI rats) and in ω3-OO versus ω3-FO rats. In each group of ω3-depleted rats, age-related changes were also monitored. The ω3-depleted rats displayed low long-chain polyunsaturated ω3 fatty acid content, facilitated metabolism of long-chain polyunsaturated ω6 fatty acids, and increased Δ9-desaturase activity. Both the age-related changes in lipid variables and those attributable to the prior intravenous injection of the ω3-rich lipid emulsion consisted either in a move towards normalization or in the opposite direction, i.e. towards aggravation of the defect found in the ω3-depleted rats. Emphasis is placed, therefore, on the unusual situation found in the soleus muscle of ω3-depleted rats, in which both lipid and metabolic variables may be either favourably or adversely affected by the same environmental factor(s).
Introduction
In a recent study, conducted in the framework of investigations dealing with the metabolic, hormonal and functional perturbations, found in second generation rats depleted in long-chain polyunsaturated ω3 fatty acids (1-6), differences were found between these rats and control animals in terms of D-glucose metabolism in stretched soleus muscles incubated in vitro in the absence or presence of insulin (1) . In this prior study, advantage was also taken from the bolus intravenous administration to the ω3-depleted rats 60-120 min before sacrifice of an ω3 fatty acid-rich medium-chain triglyceride:fish oil emulsion (MCT:FO), as compared to an ω3 fatty acid-poor medium-chain triglyceride:olive oil emulsion (MCT:OO), to assess rapid changes in muscle metabolic variables possibly resulting from the enrichment of phospholipids in long-chain polyunsaturated ω3 fatty acids, as achieved under these experimental conditions in several cell types (1, 3, 4) .
The present study concerns a comparison between uninjected ω3-depleted rats and control animals, as well as between ω3-depleted rats injected intravenously with either the MCT:FO or MCT:OO emulsion, in terms of the fatty acid content and pattern of soleus muscle phospholipids and triglycerides. Moreover, the possible occurrence of agerelated changes in these lipid variables in non-injected ω3-depleted rats (ω3-NI) and those injected with the MCT:FO (ω3-FO) or MCT:OO (ω3-OO) emulsion were examined in animals of increasing age (8-9, 15-16, and 22-23 weeks). The results of the present study thus provide three sets of information. First, it documents vast differences between ω3-NI rats and control animals. Second, it reveals age-related changes in the ω3-depleted rats. Last, it indicates, as already observed for the metabolism of D-glucose in the soleus muscle, that the prior injection of the MCT:FO emulsion may either move selected variables towards the values otherwise found in control animals or, on the contrary, accentuate the anomaly otherwise observed in ω3-NI or ω3-OO rats.
Materials and methods
Sixteen female normal rats and 78 female second generation ω3-depleted rats were given free access to either a control diet or an ω3-depleted diet, up to the time of sacrifice. Each of three groups of ω3-depleted rats (18 ω3-NI, 30 ω3-OO and 30 ω3-FO) consisted of equal numbers of rats with increasing ages (8-9, 15-16 and 22-23 weeks), so that the overall mean age of these ω3-depleted rats was similar to that of the control animals. The ω3-OO and ω3-FO rats were injected intravenously, 60-120 min before sacrifice, with 1.0 ml of either the MCT:OO or MCT:FO emulsion. The composition of the diets given to the control and ω3-depleted rats, as well as that of the two lipid emulsions were previously provided (4) . Likewise, the method used to measure the phospholipid and triglyceride fatty acid content and the pattern in extracts from the soleus muscle was described in a prior publication (7) .
The metabolic and hormonal status of the rats used in the present study was reported in a recent publication (8) .
For the sake of simplicity, the fatty acids listed in the Tables were restricted to those considered in the Results section.
All results were presented as mean values (± SEM), together with the number of individual observations (n). The statistical significance of differences between mean values was assessed by use of the Student's t-test or, whenever so required, by covariance analysis.
Results

Phospholipids.
The results of the measurements made in soleus muscle phospholipids are summarized in Tables I and  II. The total fatty acid content was lower (p<0.001) in ω3-NI rats (8.94±0.12 mg/g wet wt; n=18) than in control animals (10.41±0.32 mg/g; n=16). In the ω3-depleted rats, it failed to display any age-related change and failed to differ significantly in ω3-NI, ω3-OO (9.09±0.19; n=30) and ω3-FO rats (8.99±0.16; n=30).
Long-chain polyunsaturated ω3 fatty acids. In control animals, C18:3ω3 and C20:5ω3 accounted, respectively, for 0.25±0.03 and 0.26±0.01% of the total fatty acid content of muscle phospholipids. These two ω3 fatty acids remained below the limit of detection in all ω3-NI (n=18) and ω3-OO rats (n=30). In the ω3-FO rats, C18:3ω3 was also never detected, whilst C20:5ω3 (0.18%) was only found in one out of 30 animals.
The weight percentage of C22:5ω3 and C22:6ω3 was approximately ten times lower in ω3-depleted rats than in control animals. Both at 60 and at 120 min after injection of the lipid emulsions, the C22:5ω3 content of phospholipids was higher in ω3-FO than in ω3-OO rats. Pooling together the data obtained at different ages, the value found in ω3-FO rats averaged 109.7±3.7% (n=30; p<0.03) of the corresponding mean values recorded at the same age and same time after injection of the emulsion in ω3-OO rats (100.0±2.1%; n=30). No significant increase in the phospholipid C22:6ω3 weight percentage was found, when comparing ω3-FO to ω3-OO rats. Nevertheless, 120 min after intravenous injection of the MCT:FO emulsion, the C22:6ω3 phospholipid content averaged 110.0±4.8% (n=12; p<0.07) of the mean corresponding values found at the same age and time in ω3-OO rats (100.0±2.1%; n=12).
Whether in ω3-NI, ω3-OO or ω3-FO rats, both the absolute values (μg/g wet wt) and relative values (weight percentage) of C22:5ω3 and C22:6ω3 augmented progressively with increasing age (Table III) . These findings led us to investigate whether other phospholipid variables also displayed agerelated changes in the ω3-depleted rats.
The paired C22:6ω3/C22:5ω3 ratio in muscle phospholipids averaged 4.41±0.16 (n=18) in ω3-NI rats, 4.20±0.12 (n=29) in ω3-OO rats and 4.17±0.18 (n=30) in ω3-FO rats. These mean values were not significantly different from one another and much lower (p<0.001) than that recorded in Table I . Phospholipid fatty acid content and pattern in control and ω3-NI rats. 
control animals (7.23±0.23; n=16). In the ω3-depleted rats, this ratio underwent an up-and-down evolution with increasing age. Indeed, it first increased (p<0.001) from 3.71±0.08 (n=25) in 8-to 9-week-old rats to 4.76±0.14 (n=26) in 15-to 16-week-old rats, and then decreased (p<0.02) to 4.22±0.17 (n=26) in 22-to 23-week-old ω3-depleted rats.
Long-chain polyunsaturated ω6 fatty acids. The weight percentage of the three major long-chain polyunsaturated ω6 fatty acids in muscle phospholipids, i.e. C18:2ω6, C20:4ω6 and C22:4ω6, were much higher (p<0.001) in ω3-depleted rats than in control animals. The values recorded in ω3-NI rats (n=18) and control animals (n=16) averaged, respectively 25.35±0.31 and 19.59±0.37 in the case of C18:2ω6, 28.82±0.25 and 18.67±0.26 in the case of C20:4ω6, and 2.33±0.05 and 0.69±0.02 in the case of C22:4ω6.
In the ω3-depleted rats, the relative contribution of C18:2ω6 to the muscle phospholipids failed to display any obvious age-related changes. That of C20:4ω6, however, progressively increased with age (p<0.001). Indeed relative to the overall mean value found in the same type of ω3-depleted rats (ω3-NI, ω3-OO or ω3-FO rats), it represented (n=26 in all cases) 97.6±0.8, 99.3±1.1 and 103.1±0.7% at 8-9, 15-16 and 22-23 weeks of age. Inversely, the weight percentage of C22:4ω6 progressively decreased from 2.72±0.05% in the young rats to 2.36±0.04 and 2.15±0.03% (n=26 in all cases; p<0.001) in middle-age and older animals.
Both the C20:4ω6/C18:2ω6 and C22:4ω6/C20:4ω6 ratios in muscle phospholipids were significantly higher (p<0.001) in ω3-depleted rats than in control animals, suggesting facilitated metabolism in the sequence of reactions involved in the generation of C20:4ω6 from C18:2ω6 and C22:4ω6 from C20:4ω6 in the ω3-depleted rats. The C20:4ω6/C18:2ω6 and C22:4ω6/C20:4ω6 ratios averaged, respectively, 1.142±0.023 and 0.081±0.002 (n=18 in both cases) in ω3-NI rats, as distinct from 0.959±0.026 and 0.036±0.001 (n=16 in both cases) in control animals. The C22:4ω6/C20:4ω6 ratio, but not the C20:4ω6/C18:2ω6 ratio, underwent an obvious Table II . Phospholipid fatty acid content and pattern in ω3-OO and ω3-FO rats. Table III . Absolute and relative values for the phospholipid content of C22:5ω3 and C22:6ω3 in ω3-depleted rats of increasing age.
28.7±1. 
age-related change in the ω3-depleted rats. Relative to the overall mean value found in each group of ω3-depleted rats (ω3-NI, ω3-OO and ω3-FO), the results recorded in young, middle-age and older rats for the phospholipid C22:4ω6/ C20:4ω6 ratio averaged, respectively, 115.5±2.0, 98.4±1.5, and 86.1±1.1% (n=26 in all cases); these three mean values being significantly different (p<0.001) from one another.
Relative to the mean value recorded at the same age in ω3-OO rats, the C20:4ω6/C18:2ω6 ratio and the C22:4ω6/ C20:4ω6 ratio in muscle phospholipids averaged, respectively, in the ω3-FO rats 94.6±3.4 and 103.1±1.1% (n=30 in both cases); these two percentages being significantly different from one another (p<0.025). Even when taking into account the SEM on the mean values recorded in both ω3-OO and ω3-FO rats for these two ratios, the lowest results obtained in ω3-depleted rats injected with either the MCT-OO or MCT-FO emulsion (95.8±1.8%; n=60) yielded a p value <0.06 when compared to the mean measurements made in ω3-depleted rats injected with the other lipid emulsion (100.0±1.3%; n=60). In other words, while the injection of the MCT-FO emulsion moved the phospholipid C20:4ω6/C18:2ω6 ratio towards normal values, it affected the C22:4ω6/C20:4ω6 ratio in the opposite direction.
C16 and C18 fatty acids. The C16:1ω7/C16:0 ratio in phospholipids was much higher (p<0.001) in ω3-depleted rats (28.2±0.6x10 -3 ; n=78) than in control animals (12.6±0.5x10 -3 ; n=13). As a matter of fact in three control animals, no C16:1ω7 could be detected in the phospholipid, whilst such was never the case in ω3-depleted rats. In the latter animals, the phospholipid C16:1ω7/C16:0 ratio was significantly higher in ω3-FO than in ω3-OO rats, averaging in the former animals 109.6±3.6% (n=30; p<0.05) of the mean corresponding values found in ω3-OO rats of the same age (100.0±2.6%; n=30). In the ω3-depleted rats, the phospholipid C16:1ω7/C16:0 ratio was also related to the age of the animals. It increased (p<0.05 or less) from 25.9±0.9x10 -3 (n=26) in the youngest animals to 28.9±1.1x10 -3 and 29.8±0.8x10 -3 (n=26 in both cases) in 15-to 16-and 22-to 23-week-old rats, respectively. Thus, both the difference between ω3-OO versus ω3-FO rats and the age-related increase in the phospholipid C16:1ω7/C16:0 ratio in ω3-depleted animals were in opposite direction of that otherwise expected from a normalization of this variable linked to the corresponding changes of the phospholipid content in longchain polyunsaturated ω3 fatty acids.
The C18:1ω9/C18:0 paired ratio in muscle phospholipids was also higher (p<0.001) in ω3-NI (0.286±0.005; n=18), ω3-OO (0.292±0.003; n=30) and ω3-FO rats (0.305±0.005; n=30) than in control animals (0.202±0.005; n=16). No significant age-related changes in this ratio were observed in the ω3-depleted rats. However, as indicated by the mean values just mentioned, the C18:1ω9/C18:0 ratio was higher (p<0.01 or less) in the ω3-FO rats than in either the ω3-NI or ω3-OO rats; the measurements made in the latter two groups of animals being comparable to one another (p>0.2). In respect to both the difference between the control and ω3-depleted rats and that between the ω3-FO and ω3-OO rats, the findings concerning the phospholipid C18:1ω9/C18:0 ratio were thus similar to those recorded in the case of the phospholipid C16:1ω7/C16:0 ratio.
Finally, the activity of elongase was judged from the (C18:0 + C18:1ω9)/(C16:0 + C16:1ω7) ratio in muscle phospholipids. Such a ratio was not significantly different in the control (1.414±0.025; n=16), ω3-NI (1.445±0.021; n=18), ω3-OO (1.430±0.019; n=30) and ω3-FO rats (1.397±0.022; n=30). Likewise, in the ω3-depleted rats, it was little affected by the age of the animals, averaging 1.417±0.018 (n=26) in 8-to 9-week-old rats, 1.378±0.020 (n=26) in 15-to 16-weekold rats and 1.468±0.014 (n=26) in 22-to 23-week-old rats. Only the latter mean value was slightly higher (p<0.05 or less) than the two former ones.
Triglycerides. The data relative to the fatty acid content and pattern of muscle triglycerides are summarized in Tables IV  and V. The total amount of triglyceride fatty acids in the soleus muscle displayed considerable individual variability. For instance, in the three groups of ω3-depleted rats (ω3-NI, ω3-OO and ω3-FO), its coefficient of variation averaged 104.9±3.1% (n=3), as compared to only 9.1±1.6% (n=3) for the total fatty acid content of muscle phospholipids in the same animals. No significant difference in such a total amount of triglyceride fatty acids was found when comparing ω3-NI, ω3-OO or ω3-FO rats to control animals.
Advantage was then taken from the inverse relationship between such a total amount of triglyceride fatty acids and their relative content (percent) in C20:4ω6 (9) to compare the relationship between these two variables in ω3-depleted rats and control animals. The latter relationship displaying a hyperbolic pattern, the product of the neperian logarithm of the total triglyceride fatty acid content (μg/g wet wt) by the weight percentage of C20:4ω6 was calculated in each rat. It averaged, in ω3-NI rats, 21.37±0.90 (n=18) as distinct (p<0.01) from 25.25±1.11 (n=15) in control animals. The mean values found in the ω3-OO (22.69±1.16; n=30) and ω3-FO rats (20.44±0.77; n=30), which did not significantly differ from one another (p>0.1) or that found in ω3-NI rats, yielded an overall mean value (21.57±0.70; n=60) also significantly lower (p<0.02) than that recorded in the control animals. These results document a different relationship between the total fatty acid content of muscle triglyceride and their relative content of C20:4ω6 in ω3-depleted rats as compared to control animals. The biological significance of this difference is considered in the Discussion section of the present report.
Long-chain polyunsaturated ω3 fatty acids. In control animals, the weight percentage of C18:3ω3, C20:5ω3, C22:5ω3 and C26:ω3 in muscle triglycerides represented, respectively, 3.07±0.10, 0.12±0.04, 1.18±0.14 and 2.73±0.30 (n=15 in all cases). Only C20:5ω3 remained below the limit of detection in 9 out of 15 animals. In these 15 control rats, the C22:6ω3/C22:5ω3 ratio in triglycerides averaged 2.306±0.099.
In ω3-NI rats, none of these long-chain polyunsaturated ω3 fatty acids could be detected (n=18 in each case). As a rule, these ω3 fatty acids also remained below the limit of detection in ω3-OO and ω3-FO rats. Only 7 out of 60 ω3-depleted rats injected with a lipid emulsion and with a high total fatty acid content in triglycerides (27.5±3.7 mg/g wet wt) contained detectable amounts of C18:3ω3 in muscle triglycerides, with a mean weight percentage in these 7 animals of 0.10±0.01, i.e. ~30 times lower than in control rats. No C20:5ω3 was detected in any of the 60 ω3-OO and ω3-FO rats. A sizeable amount of either C22:5ω3 or C22:6ω3 was only found in 5 of these 60 rats. It represented no more than 0.36±0.18% of the total fatty acid content of triglycerides, itself usually again in the high range of individual values. Table IV . Triglyceride fatty acid content and pattern in control and ω3-NI rats. 153±12 (15) 220±22 (6) 212±15 (6) 229±27 (6) Table V . Triglyceride fatty acid content and pattern in ω3-OO and ω3-FO rats. C22:4ω6/C20:4ω6 (x10 3 ) 366±53 (7) 300±23 (7) 248±16 (9) 297±16 (7) 257±19 (8) 234±11 (
cite only one example, the correlation coefficient between the C16:1ω7/C16:0 and C18:1ω9/C18:0 ratios in muscle triglycerides and the total fatty acid content of such triglycerides (logarithmic value) averaged, respectively, 0.7570 and 0.9311 (n=18 and p<0.001 in both cases) in ω3-NI rats, 0.7144 and 0.8542 (n=30 and p<0.001 in both cases) in ω3-OO rats, and 0.4405 and 0.8346 (n=30 in both cases; p<0.05 or less) in ω3-FO rats.
Discussion
The present results deal with three interrelated issues, namely differences in muscle phospholipid and triglyceride fatty acid content and the pattern between i) control and ω3-NI rats, ii) ω3-depleted rats of increasing age, and iii) ω3-OO versus ω3-FO rats.
Concerning the first of these three issues, the major findings were as follows. The total fatty acid content of muscle phospholipids was lower in ω3-depleted rats than in control animals. A comparable situation was recently found in the cardiac muscle of the same animals (9) . At first glance, the fact that the product between the logarithm of the total fatty acid content of triglycerides by their C20:4ω6 weight percentage was significantly lower in ω3-depleted rats than in control animals does not suggest the presence, in the former rats, of muscle steatosis, at variance with the presence of liver steatosis in the same animals (3, 8) . Nevertheless, this finding indicates that, for a given total amount of triglycerides in the soleus muscle, the C20:4ω6 weight percentage is lower in ω3-depleted rats than in control animals. Since the content of C20:4ω6 is extremely low in adipocyte lipids (3), the latter consideration supports the view that the relative contribution of adipocyte-type triglycerides to the total amount of muscle triglycerides is higher in ω3-depleted rats than in control animals (10) .
In terms of the phospholipid fatty acid pattern and in addition to the expected depletion in ω3 fatty acids with low C22:6ω3/C22:5ω3 ratio, and the increase in ω6 fatty acid content with elevated C20:4ω6/C18:3ω6 and C22:4ω6/ C20:4ω6 ratios, the ω3-depleted rats displayed increased activity of Δ9-desaturase, as judged from both the C16:1ω7/ C16:0 and C18:1ω9/C18:0 ratios, and unchanged activity of elongase, as judged from the (C18:0 + C18:1ω9)/(C16:0 + C16:1ω7) ratio. Likewise, in the muscle triglycerides of ω3-depleted rats, a depletion of long-chain polyunsaturated ω3 fatty acids and a facilitated generation of long-chain polyunsaturated ω6 fatty acids from their precursors coincided with higher C16:1ω7/ C16:0 and C18:1ω9/C18:0 ratios and, in this case, an elevated (C18:0 + C18:1ω9)/(C16:0 + C16:1ω7) ratio.
Several of the lipid variables displayed age-related changes in the ω3-depleted rats. Such was the case, for instance, for a progressive increase of the phospholipid content in C22:5ω3, C22:6ω3 and C20:4ω6 and phospholipid C16:1ω7/C16:0 ratio and a progressive decrease in the C22:4ω6 and C22:4ω6/C20:4ω6 ratio in the same phospholipids. Likewise, in muscle triglycerides of ω3-depleted rats, an age-related increase in the C20:4ω6 content and (C18:0 + C18:1ω9)/(C16:0 + C16:1ω7) ratio was observed. Most of these changes shifted in the direction of the values otherwise found in control rats and, hence, could be considered as a trend towards normalization. Such is not the case, however, for the age-related change in the phospholipid C20:4ω6 and C16:1ω7/C16:0 ratio.
A comparable dichotomy characterized the differences between ω3-OO and ω3-FO rats. Indeed, on one hand, the increase in the phospholipid content of C22:5ω3 and C22:6ω3 found in the latter rats, as well as the lowering of the C20:4ω6/C18:2ω6 ratio found in both the phospholipids and triglycerides of ω3-FO rats and that of the C22:4ω6/ C20:4ω6 ratio in their triglycerides, can all be considered as a move towards the values otherwise found in control animals. On the other hand, however, the higher values for the C16:1ω7/C16:0 and C18:1ω9/C18:0 ratios found in both the phospholipids and triglycerides of ω3-FO rats, as compared to ω3-OO rats, accentuate the difference otherwise recorded when comparing ω3-depleted rats to control animals.
The opposite directions of both age-related changes in selected lipid variables of ω3-depleted rats and those attributable to the prior injection of the MCT:FO emulsion (as distinct from the MCT:OO emulsion), i.e. the move either towards correction or accentuation of the anomalies found in ω3-depleted rats, are reminiscent of comparable findings made when considering the difference between ω3-OO and ω3-FO rats in terms of the metabolism of D-glucose in stretched soleus muscle examined ex vivo (1) .
In our opinion, such an analogy calls for further investigation on the possible cause-to-effect link between selected lipid variables, e.g. the activity in Δ9-desaturase and resulting C16:1ω7/C16:0 and C18:1ω9/C18:0 ratios in muscle phospholipids, and selected metabolic variables, e.g. the net rate of glycogen synthesis, which are both higher in ω3-depleted rats than in control animals and both further increased in the ω3-FO rats. In the same perspective, in the ω3-deprived rats, the depletion of phospholipids in longchain polyunsaturated ω3 fatty acids and their abnormally high content in long-chain polyunsaturated ω6 fatty acids could somehow account for a low ratio between the output of 14 C-labelled amino acids and acidic metabolites found in the soleus muscle of ω3-OO rats (as compared to control animals) exposed in vitro to D-[U-14 C]glucose; both these lipid and metabolic defects being counteracted by the prior intravenous injection of the MCT:FO emulsion.
In conclusion, therefore, the present work draws attention to the unusual situation found in the skeletal muscle of ω3-depleted rats, in which obvious dissimilarities, i.e. either normalization or aggravation, are observed when considering the changes attributable to differences in age, in terms of the fatty acid pattern of cell lipids, and those attributable to the prior intravenous injection of an ω3-rich lipid emulsion, in terms of both the fatty acid pattern and the metabolism of Dglucose in soleus muscle.
